scholarly article | Q13442814 |
P356 | DOI | 10.3325/CMJ.2016.57.16 |
P8608 | Fatcat ID | release_jx6puizmcfekzotc7udid6si6e |
P932 | PMC publication ID | 4800331 |
P698 | PubMed publication ID | 26935611 |
P5875 | ResearchGate publication ID | 299655708 |
P2093 | author name string | Christian Schulz | |
Ernst Holler | |||
Diana Ditz | |||
Daniel Wolff | |||
Barbara Holler | |||
Gerhard Carl Hildebrandt | |||
Robert Rabanus | |||
P2860 | cites work | Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors | Q70051817 |
Bronchiolitis obliterans after bone marrow transplantation: the effect of preconditioning | Q72858204 | ||
Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan and allogeneic transplantation | Q74249616 | ||
Association of pulmonary function testing abnormalities and severe veno-occlusive disease of the liver after marrow transplantation | Q74724507 | ||
Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation | Q78020367 | ||
Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes | Q79188124 | ||
Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of | Q80078439 | ||
Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia | Q80345532 | ||
Chronic graft-versus-host disease | Q81762610 | ||
Small airways function declines after allogeneic haematopoietic stem cell transplantation | Q84086220 | ||
Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens | Q84217947 | ||
Interpretative strategies for lung function tests | Q28279970 | ||
Pulmonary function changes in long-term survivors of bone marrow transplantation | Q28290958 | ||
Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society | Q29616361 | ||
Lung function and long-term complications after allogeneic hematopoietic cell transplant | Q33584196 | ||
Engraftment syndrome following hematopoietic stem cell transplantation | Q34298239 | ||
Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. | Q34365477 | ||
Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation | Q34396430 | ||
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report | Q34474243 | ||
Pulmonary function abnormalities after allogeneic marrow transplantation: a systematic review and assessment of an existing predictive instrument | Q34983855 | ||
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report | Q35085226 | ||
Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants | Q35180225 | ||
Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease | Q35293711 | ||
Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation. | Q35745142 | ||
Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation | Q35848787 | ||
Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study | Q35849241 | ||
Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease? | Q35858408 | ||
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study | Q36141716 | ||
Acute lung injury after allogeneic stem cell transplantation: from the clinic, to the bench and back again | Q36321249 | ||
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. | Q36407176 | ||
Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group repor | Q36554724 | ||
Carbon monoxide diffusion capacity: how low can you go for hematopoietic cell transplantation eligibility? | Q37177449 | ||
Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation | Q37282816 | ||
Late pulmonary, cardiovascular, and renal complications after hematopoietic stem cell transplantation and recommended screening practices | Q37346702 | ||
Lung function, pulmonary complications, and mortality after allogeneic blood and marrow transplantation in children | Q37524729 | ||
Engraftment syndrome following allogeneic hematopoietic stem cell transplantation in children | Q40402680 | ||
The immunopathophysiology of acute graft-versus-host-disease | Q41185700 | ||
Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation | Q43579107 | ||
Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation | Q44723606 | ||
Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation. | Q44750603 | ||
Implications of early airflow decline after myeloablative allogeneic stem cell transplantation | Q48018968 | ||
Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect. | Q51659830 | ||
Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. | Q51681296 | ||
Quality of life in 244 recipients of allogeneic bone marrow transplantation. | Q53512272 | ||
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. | Q54684597 | ||
A chronic pulmonary syndrome associated with graft-versus-host disease after allogeneic marrow transplantation | Q67966340 | ||
P433 | issue | 1 | |
P304 | page(s) | 16-28 | |
P577 | publication date | 2016-02-01 | |
P1433 | published in | Croatian Medical Journal | Q15750362 |
P1476 | title | The lung function score and its components as predictors of overall survival and chronic graft-vs-host disease after allogeneic stem cell transplantation | |
P478 | volume | 57 |
Q56516417 | Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients | cites work | P2860 |
Search more.